Articles

The ‘split’ you discuss should be more about estate planning than contemplating a future divorce

Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.

Nvidia’s CEO has an “outsize role and unclear succession.”

Black Friday could be the perfect time to buy one.

Some investors worried that SpaceX’s volatile stock would have an extreme impact on indexes, but the company’s staggered lockup schedule has mitigated this issue.

“It would be a less drastic step than selling the home now and splitting the proceeds.”

Precisely because it has long been hamstrung by rigid labor markets and overregulation, European stocks may paradoxically be bigger beneficiaries of the AI revolution in terms of enhanced productivity and cost-cutting than its U.S. counterparts

The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

Americans are more concerned about retirement than ever, and some of their biggest fears can’t be fixed by individual behavior alone.

After a bruising stretch for tech stocks, investors face fresh questions about leadership, valuations and the cost of the AI boom. Plus, a Taylor Swift encore for one 72-year-old retiree.

Despite recent weakness, Citi’s global strategy team thinks tech positioning needs to get cleaner before they would revert to their previous overweight stance.

The dismal performance of Geico is the biggest takeaway from Berkshire Hathaway’s third-quarter results.